Literature DB >> 10646958

Long term prognosis after CABG in relation to preoperative left ventricular ejection fraction.

J Herlitz1, B W Karlson, H Sjöland, G Brandrup-Wognsen, M Haglid, T Karlsson, K Caidahl.   

Abstract

AIM: To evaluate the mortality rate, risk indicators for death, mode of death and symptoms of angina pectoris during 5 years after coronary artery by pass grafting (CABG) in relation to the preoperative left ventricular ejection fraction (LVEF). PATIENTS: All patients in western Sweden who underwent CABG without concomitant valve surgery and without previously performed CABG between June 1988 and June 1991.
RESULTS: In all 1904 patients were included in the analysis, of whom 173 (9%) had a LVEF < 40%. Patients with LVEF > or = 40% had a 5-year mortality of 12.5%. LVEF < 40% was associated with an increased risk of death (RR 2.3; 95% cl 1.7-3.1). There was no significant interaction between age, sex or any other factor in terms of clinical history and LVEF. However, left main stenosis was a strong independent predictor of death among patients with LVEF < 40% but not in those with a higher LVEF. Patients with a low LVEF more frequently died a cardiac death and a death associated with myocardial infarction (AMI). Furthermore they more frequently died in association with congestive heart failure and ventricular fibrillation. Among survivors, symptoms of angina pectoris were similar regardless of the preoperative LVEF.
CONCLUSION: Patients with a low preoperative LVEF have a more than two-fold increased risk of death during 5 years after CABG. Their increased risk of death includes cardiac death, death associated with AMI, congestive heart failure and ventricular fibrillation.

Entities:  

Mesh:

Year:  2000        PMID: 10646958     DOI: 10.1016/s0167-5273(99)00187-4

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Comparison of Echocardiography, Cardiac Magnetic Resonance, and Computed Tomographic Imaging for the Evaluation of Left Ventricular Myocardial Function: Part 1 (Global Assessment).

Authors:  Menhel Kinno; Prashant Nagpal; Stephen Horgan; Alfonso H Waller
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

2.  Long-term prognostic value of mitral regurgitation in acute coronary syndromes.

Authors:  Anita Persson; Marianne Hartford; Johan Herlitz; Thomas Karlsson; Torbjørn Omland; Kenneth Caidahl
Journal:  Heart       Date:  2010-09-28       Impact factor: 5.994

3.  Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected].

Authors:  Julio A Panza; Eric J Velazquez; Lilin She; Peter K Smith; José C Nicolau; Roberto R Favaloro; Sinisa Gradinac; Lukasz Chrzanowski; Dorairaj Prabhakaran; Jonathan G Howlett; Marek Jasinski; James A Hill; Hanna Szwed; Robert Larbalestier; Patrice Desvigne-Nickens; Robert H Jones; Kerry L Lee; Jean L Rouleau
Journal:  J Am Coll Cardiol       Date:  2014-08-12       Impact factor: 24.094

4.  Prevalence and 1-year prognosis of transient heart failure following coronary revascularization.

Authors:  Marco Ambrosetti; Raffaele Griffo; Roberto Tramarin; Francesco Fattirolli; Pier Luigi Temporelli; Pompilio Faggiano; Stefania De Feo; Anna Rita Vestri; Francesco Giallauria; Cesare Greco
Journal:  Intern Emerg Med       Date:  2013-10-22       Impact factor: 3.397

5.  PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.

Authors:  Izabela Wojtkowska; Andrzej Tysarowski; Katarzyna Seliga; Janusz A Siedlecki; Zbigniew Juraszyński; Milosz Marona; Lidia Greszata; Anna Skrobisz; Karol Kaminski; Robert Sawicki; Janina Stępińska
Journal:  PPAR Res       Date:  2014-10-13       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.